Ketogenic Diet and Schizophrenia: Promising Metabolic Therapy, Not a Cure

COMMENTARY

Psychiatry has never lacked skepticism, and frankly, some of it is deserved. Patients, families, and even clinicians often feel that lifestyle modification, particularly diet and exercise, receives far less attention than medications in the treatment of serious mental illness. That frustration has fueled growing interest in nutritional psychiatry, a field that is very real, rapidly expanding, and increasingly integrated into mainstream psychiatric research and practice.

I firmly believe diet and exercise matter. They should be part of nearly every mental-health treatment plan. But belief does not replace evidence.

That is why claims that the ketogenic diet is “curative” for schizophrenia deserve scrutiny. This is not just a bold statement; it is one that outpaces the current scientific literature.

Families affected by schizophrenia are understandably desperate for better options. Any clinician who treats psychotic disorders knows the limitations of antipsychotic medications: partial symptom control, persistent negative symptoms, cognitive impairment, and substantial metabolic burden. While medications can reduce psychosis and relapse risk, they have never been shown to cure schizophrenia.

So, the question becomes: where medications fall short, can the ketogenic diet succeed? To answer that, we need to examine what the evidence shows, and what it does not.

What Is the Ketogenic Diet?

The ketogenic diet is a very low-carbohydrate, high-fat, moderate-protein eating pattern designed to shift the body’s primary energy source from glucose to ketone bodies. Typically, carbohydrate intake is restricted to <50 g/day, inducing a metabolic state known as nutritional ketosis.¹

Standard macronutrient distribution includes:

• 70% to 80% fat
• 20% to 25% protein
• 5% to 10% carbohydrates

By lowering insulin levels and stabilizing energy metabolism, ketosis may reduce hunger, improve insulin sensitivity, and alter neurochemical signaling. Implementation usually involves eliminating refined carbohydrates, grains, sugars, and starchy vegetables, while emphasizing healthy fats (olive oil, avocado), proteins (meat, eggs, fatty fish), and low-carbohydrate vegetables (leafy greens, broccoli, cauliflower). Because ketogenic diets can have diuretic effects, hydration, electrolytes, and medical supervision are strongly recommended.¹

The diet is demanding. Adherence is not trivial, and it should not be undertaken casually, particularly in patients with serious mental illness.

Why Consider Ketogenic Diets in Schizophrenia?

The rationale begins with a paradox clinicians know well: antipsychotics improve psychosis but worsen metabolic health. Weight gain, insulin resistance, dyslipidemia, and cardiovascular disease are common contributors to nonadherence and premature mortality in schizophrenia.

Ketogenic diets were first used therapeutically in refractory epilepsy, where they reduce neuronal excitability. This observation has led to hypotheses that ketosis may influence psychiatric symptoms through:

• Increased GABAergic tone relative to glutamatergic activity
• Improved mitochondrial function
• Reduced oxidative stress and systemic inflammation
• Improved insulin sensitivity and metabolic health

These mechanisms are biologically plausible, but plausibility is not proof.

What Does the Clinical Evidence Show?

Early Case Reports

The earliest report dates to 1965, describing 10 women with chronic schizophrenia who followed a ketogenic diet for 2 weeks while continuing standard psychiatric treatment.² Investigators reported noticeable symptom reduction during ketosis, with partial relapse after discontinuation. This study was open-label, short-term, and uncontrolled, with a very small sample size, limitations that mirror many early reports in this space.

Stanford Pilot Trial (2024)

A more recent 4-month pilot study from Stanford evaluated 21 adults with schizophrenia or bipolar disorder, all of whom were taking antipsychotics and had metabolic abnormalities.³ Participants followed a ketogenic diet providing 10% carbohydrates, 30% protein, and 60% fat, supported by meal plans, cookbooks, and health coaching.

Key findings:

• 29% met criteria for metabolic syndrome at baseline; 0% did at 4 months
• Mean weight loss was approximately 10%
• Significant reductions in waist circumference, blood pressure, triglycerides, and insulin resistance
• Investigators saw 31% improvement on the Clinical Global Impression scale
• Patients had improved sleep and quality of life

These results are impressive, particularly from a metabolic health standpoint. But context matters:

• Participants were clinically stable
• All remained on psychiatric medications
• The sample was small and heterogeneous
• There was no control group

Nothing in this study supports the claim that ketogenic diets are curative for schizophrenia.

Retrospective Inpatient Analysis

A retrospective analysis of 31 inpatients with refractory mental illness placed on a ketogenic diet showed significant psychiatric improvement compared with standard hospital diets.⁴ Of note:

• 10 participants had schizoaffective disorder
• None were diagnosed with schizophrenia
• All were receiving standard inpatient treatment and psychotropic medications
• PANSS scores in schizoaffective patients dropped dramatically (Cohen’s d ≈ 3.5)

While clinically meaningful, this was an open-label, nonrandomized inpatient study, conducted in a highly structured environment with intensive support. It does not demonstrate disease remission, medication independence, or durability of effect outside that setting.

What About Ongoing Trials?

Several randomized controlled trials are currently underway, including a 14-week RCT enrolling approximately 100 outpatients with schizophrenia, schizoaffective disorder, or bipolar disorder receiving ketogenic metabolic therapy.⁵ Stanford has also registered additional metabolic psychiatry studies, though results are pending.

These trials are essential, and until they report, claims of cure are premature.

Is the Ketogenic Diet a Cure for Schizophrenia?

No. Based on the current evidence:

• There is no signal that ketogenic diets cure schizophrenia
• There is no evidence they allow sustained remission without medication
• There is encouraging evidence for improving metabolic health
• There may be modest improvements in psychiatric symptoms in select, stable patients

That is not nothing, but it is not a cure. Promising early data from small, open-label studies should generate careful optimism, not viral certainty. Overstating these findings risks offering false hope and misrepresenting where the science stands.

Diet matters. Metabolic health matters. Nutritional psychiatry is real. But science moves slower than social media, and until large, well-controlled trials show otherwise, the ketogenic diet should be viewed as a potential adjunctive metabolic therapy, not a curative treatment for schizophrenia.

That is not pessimism; That is honesty. And in psychiatry, honesty matters.

Dr Rossi is a board-certified psychiatrist specializing in inpatient and consultation-liaison psychiatry. His work focuses on evidence-based treatment, complex mood and psychotic disorders, and practical clinical decision-making. He is passionate about education, thoughtful skepticism, and advancing psychiatry through honest, nuanced discussion.

References

1. Daley SF, Masood W, Annamaraju P, Suheb MZK. The Ketogenic Diet: Clinical Applications, Evidence-Based Indications, and Implementation. StatPearls Publishing; 2025.

2. Pacheco A, Easterling WS, Pryer MW. A pilot study of the ketogenic diet in schizophrenia. Am J Psychiatry.1965;121:1110-1111.

3. Sethi S, Wakeham D, Ketter T, et al. Ketogenic diet intervention on metabolic and psychiatric health in bipolar disorder and schizophrenia: a pilot trial. Psychiatry Res. 2024;335:115866.

4. Danan A, Westman EC, Saslow LR, Ede G. The ketogenic diet for refractory mental illness: a retrospective analysis of 31 inpatients. Front Psychiatry. 2022;13:951376.

5. Longhitano C, Finlay S, Peachey I, et al. Effects of ketogenic metabolic therapy on mental health and metabolic outcomes in schizophrenia and bipolar disorder: a randomized controlled trial protocol. Front Nutr. 2024;11:1444483.